The inhibition of YAP Signaling Prevents Chronic Biliary Fibrosis in the Abcb4<sup>-/-</sup> Model by Modulation of Hepatic Stellate Cell and Bile Duct Epithelium Cell Pathophysiology-Reference-Cited by-同舟云学术

The inhibition of YAP Signaling Prevents Chronic Biliary Fibrosis in the Abcb4^-/- Model by Modulation of Hepatic Stellate Cell and Bile Duct Epithelium Cell Pathophysiology

Published:2024 Issue:1 Volume:15 Page:338
ISSN:2152-5250
Container-title:Aging and disease
language:en
Short-container-title:Aging and disease

Author:

Ye Liangtao,Ziesch Andreas,Schneider Julia S.,Ofner Andrea,Nieß Hanno,Denk Gerald,Hohenester Simon,Mayr Doris,Mahajan Ujjwal M.,Munker Stefan,Khaled Najib Ben,Wimmer Ralf,Gerbes Alexander L.,Mayerle Julia,He Yulong,Geier Andreas,Toni Enrico N. De,Zhang Changhua,Reiter Florian P.

Publisher

Aging and Disease

Reference52 articles.

1. Bataller R, Brenner DA (2005). Liver fibrosis. J Clin Invest, 115:209-218.

2. Poynard T, Lebray P, Ingiliz P, Varaut A, Varsat B, Ngo Y, et al. (2010). Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest). BMC Gastroenterol, 10:40.

3. Mokdad AA, Lopez AD, Shahraz S, Lozano R, Mokdad AH, Stanaway J, et al. (2014). Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med, 12:145.

4. Mannaerts I, Leite SB, Verhulst S, Claerhout S, Eysackers N, Thoen LF, et al. (2015). The Hippo pathway effector YAP controls mouse hepatic stellate cell activation. J Hepatol, 63:679-688.

5. Martin K, Pritchett J, Llewellyn J, Mullan AF, Athwal VS, Dobie R, et al. (2016). PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis. Nat Commun, 7:12502.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Management of Dysfunctional Gallbladder Disease and the Role of Laparoscopic Cholecystectomy on Symptom Improvement: A Retrospective Cohort Study;Cureus;2024-07-17

2. Targeting TAM-secreted S100A9 effectively enhances the tumor-suppressive effect of metformin in treating lung adenocarcinoma;Cancer Letters;2024-01

3. Unraveling the Complexities of Fibrosis and Ductular Reaction in Liver Disease: Pathogenesis, Mechanisms, and Therapeutic Insights;American Journal of Physiology-Cell Physiology;2023-12-18